Similarly, our qRT-PCR analysis for the developing VM revealed a rather small 3 fold up-regulation of FGF-2 and a striking 80 fold up-regulation of FGF-1 between E14.5 and AD stage. This evidence concerns the gene FGF1 and Alzheimer disease.